SCHEMBL16168979

SCHEMBL16168979

CN(C)c1nn(C)c2ccc(N)cc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 1/20 0.37
▸ DDB1 Q16531 2/20 0.36
▸ CRBN Q96SW2 2/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ HBB P68871 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NSD2 O96028 1/20 0.35
▸ BRPF1 P55201 2/20 0.34
▸ EGFR P00533 2/20 0.34
▸ AXL P30530 1/20 0.33
▸ PABPC1 P11940 1/20 0.33
▸ ADORA2A P29274 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16165048 0.82 CHEK1 (0.35) PRKCIDDB1CRBNALDH1A1MAPT
SCHEMBL15345098 0.81 KDR (0.38) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL15333881 0.79 DNM1 (0.41) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL15081231 0.78 CRHR1 (0.35) PRKCIDDB1CRBNALDH1A1MAPT
SCHEMBL3655093 0.78 PRKCI (0.41) PRKCIDDB1CRBNALDH1A1MAPT
SCHEMBL15341793 0.77 EGLN1 (0.38) ALDH1A1HTTADORA2AADORA2B
SCHEMBL3376205 0.77 ADORA2A (0.59) PRKCIDDB1CRBNALDH1A1MAPT
SCHEMBL29992674 0.77 ADORA2A (0.59) PRKCIDDB1CRBNALDH1A1MAPT
SCHEMBL16165667 0.76 CHEK1 (0.39) ALDH1A1MAPTKDM4EHSD17B10MAPK1
SCHEMBL15081403 0.76 CNR2 (0.38) PRKCIALDH1A1MAPTKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2799431-B1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORP (JP) 2018-01-24 — — EP disclosed
US-9051310-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2015-06-09 — — US disclosed
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 — — US disclosed
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, BTK, NOX4 PRKCI 1049/4885DDB1 4383/4885CRBN 1689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback